Literature DB >> 19003295

Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention.

Hans G Drexler1, Cord C Uphoff.   

Abstract

The contamination of cell cultures by mycoplasmas remains a major problem in cell culture. Mycoplasmas can produce a virtually unlimited variety of effects in the cultures they infect. These organisms are resistant to most antibiotics commonly employed in cell cultures. Here we provide a concise overview of the current knowledge on: (1) the incidence and sources of mycoplasma contamination in cell cultures, the mycoplasma species most commonly detected in cell cultures, and the effects of mycoplasmas on the function and activities of infected cell cultures; (2) the various techniques available for the detection of mycoplasmas with particular emphasis on the most reliable detection methods; (3) the various methods available for the elimination of mycoplasmas highlighting antibiotic treatment; and (4) the recommended procedures and working protocols for the detection, elimination and prevention of mycoplasma contamination. The availability of accurate, sensitive and reliable detection methods and the application of robust and successful elimination methods provide powerful means for overcoming the problem of mycoplasma contamination in cell cultures.

Entities:  

Year:  2002        PMID: 19003295      PMCID: PMC3463982          DOI: 10.1023/A:1022913015916

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  19 in total

Review 1.  Detection of mycoplasma contaminations in cell cultures by PCR analysis.

Authors:  C C Uphoff; H G Drexler
Journal:  Hum Cell       Date:  1999-12       Impact factor: 4.174

2.  Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.

Authors:  C C Uphoff; C Meyer; H G Drexler
Journal:  Leukemia       Date:  2002-02       Impact factor: 11.528

Review 3.  Advances in PCR-based detection of mycoplasmas contaminating cell cultures.

Authors:  G Rawadi; O Dussurget
Journal:  PCR Methods Appl       Date:  1995-02

4.  Elimination of mycoplasma from infected leukemia cell lines.

Authors:  S M Gignac; S Brauer; B Häne; H Quentmeier; H G Drexler
Journal:  Leukemia       Date:  1991-02       Impact factor: 11.528

5.  Prevention of mycoplasma contamination in leukemia-lymphoma cell lines.

Authors:  C C Uphoff; H G Drexler
Journal:  Hum Cell       Date:  2001-09       Impact factor: 4.174

6.  Mix-ups and mycoplasma: the enemies within.

Authors:  Hans G Drexler; Cord C Uphoff; Willy G Dirks; Roderick A F MacLeod
Journal:  Leuk Res       Date:  2002-04       Impact factor: 3.156

Review 7.  DNA probes and PCR in diagnosis of mycoplasma infections.

Authors:  S Razin
Journal:  Mol Cell Probes       Date:  1994-12       Impact factor: 2.365

8.  Mycoplasma infection of cultured cells.

Authors:  R J Hay; M L Macy; T R Chen
Journal:  Nature       Date:  1989-06-08       Impact factor: 49.962

9.  Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines.

Authors:  A Hopert; C C Uphoff; M Wirth; H Hauser; H G Drexler
Journal:  J Immunol Methods       Date:  1993-08-26       Impact factor: 2.303

10.  Treatment of mycoplasma contamination in a large panel of cell cultures.

Authors:  H G Drexler; S M Gignac; Z B Hu; A Hopert; E Fleckenstein; M Voges; C C Uphoff
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-05       Impact factor: 2.416

View more
  100 in total

1.  Interference of Mycoplasma infection in a gene expression study: it was the environment and not the gene.

Authors:  Gregor Hoermann; Joachim Spergser; Elisa Einwallner; Athanasios Makristathis; Andrea Perne; Birgit Willinger; Ilse Schwarzinger
Journal:  Appl Environ Microbiol       Date:  2010-10-01       Impact factor: 4.792

2.  Control of the mycoplasma epidemic.

Authors:  M Jules Mattes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

3.  Tandem use of immunofluorescent and DNA staining assays to validate nested PCR detection of mycoplasma.

Authors:  Ashok Kumar; Arif Ali; Lakshmana K Yerneni
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-05       Impact factor: 2.416

4.  Best practices for the use and evaluation of animal serum as a component of cell culture medium.

Authors:  Raymond W Nims; John W Harbell
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-07-21       Impact factor: 2.416

5.  Mycoplasma Infection Mediates Sensitivity of Multidrug-Resistant Cell Lines to Tiopronin: A Cautionary Tale.

Authors:  Lyn M Huff; Sachi Horibata; Robert W Robey; Matthew D Hall; Michael M Gottesman
Journal:  J Med Chem       Date:  2020-02-04       Impact factor: 7.446

6.  Mycoplasma contamination affects cell characteristics and decreases the sensitivity of BV2 microglia to LPS stimulation.

Authors:  Nianhua Feng; Xiaoxi Huang; Yanjun Jia
Journal:  Cytotechnology       Date:  2019-04-03       Impact factor: 2.058

7.  In Vitro Differentiation of Tumor-Associated Macrophages from Monocyte Precursors with Modified Melanoma-Conditioned Medium.

Authors:  Tao Wang; Russel E Kaufman
Journal:  Methods Mol Biol       Date:  2021

8.  Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny.

Authors:  Kyriaki Markoullis; Diana Bulian; Gabriele Hölzlwimmer; Leticia Quintanilla-Martinez; Katrin-Janine Heiliger; Horst Zitzelsberger; Hagen Scherb; Josef Mysliwietz; Cord C Uphoff; Hans G Drexler; Thure Adler; Dirk H Busch; Jörg Schmidt; Esther Mahabir
Journal:  Transgenic Res       Date:  2008-09-26       Impact factor: 2.788

9.  Treatment and control of mycoplasma contamination in Plasmodium falciparum culture.

Authors:  Shubhra Singh; S K Puri; Kumkum Srivastava
Journal:  Parasitol Res       Date:  2008-09-30       Impact factor: 2.289

10.  The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection.

Authors:  Elisabetta Mariotti; Marica Gemei; Peppino Mirabelli; Francesca D'Alessio; Rosa Di Noto; Giuliana Fortunato; Luigi Del Vecchio
Journal:  BMC Cancer       Date:  2010-03-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.